Clinical Trials for Adam Esbenshade

10 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
Basic ScienceVICCPED1258
09/06/2012
Mutations in DICER1 and Related MicroRNA Processing Genes in Dysplasias, Dysontogenic Diseases, Tumors and Other Conditions
OtherCOGACNS02B3
02/04/2013
ACNS02B3 - A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens
OtherVICCPED1251
05/31/2012
Supplemental Empiric Antibiotics in Unstable Febrile Neutropenia: Indications and Outcomes - CHART REVIEW
OtherVICCPED1145
12/02/2011
Cefepime Use in Newly Diagnosed Pediatric Patients with Leukemia or Lymphoma (Retrospective Chart Review)
Supportive CareCOGACCL1131
06/12/2013
A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFi Following Allogeneic Hematopoietic Cell Transplantation (HCT)
Supportive CareVICCPED1309
03/29/2013
ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients
Supportive CareCOGACCL0922
02/20/2013
SCUSF0901 - ACCL0922: A Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor
TreatmentCOGACNS1022
06/09/2012
ACNS1022 - A Phase II Randomized Trial of Lenalidomide (NSC# 703813, InD# 70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
TreatmentCOGACNS0821
10/08/2011
ACNS0821 - Temozolomide with Irinotecan versus Temozolomide, Irinotecan plus Bevacizumab (NSC# 704865, BB-IND# 7921) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial
TreatmentCOGACNS0831
05/12/2011
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years.

Back to Find By Doctor

You do not have JavaScript enabled. This site works better with JavaScript turned on.